Novel delivery platforms for systemic or local administration of antisense oligonucleotides, siRNA or modified mRNA Highlights PEI-free, non--cytotoxicity High transfection efficiency Functional gene silencing post siRNA delivery Compatibility with diverse growth conditions (with and without serum) Easy--to--use protocols for both adherent and suspension cells In vivo and in vitro Low cost 208 USD/mg(solid)
